antimycin a has been researched along with piroxicam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bracht, A; Constantin, J; Ishii-Iwamoto, EL; Nascimento, EA; Salgueiro-Pagadigorria, CL | 1 |
2 other study(ies) available for antimycin a and piroxicam
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of the nonsteroidal anti-inflammatory drug piroxicam on energy metabolism in the perfused rat liver.
Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimycin A; Atractyloside; Drug Interactions; Energy Metabolism; Fasting; Gluconeogenesis; Glucose; Glycogen; Lactates; Lactic Acid; Liver; Male; Mitochondria, Liver; NAD; NADP; Oxygen Consumption; Perfusion; Piroxicam; Pyruvates; Pyruvic Acid; Rats; Rats, Wistar | 1996 |